Literature DB >> 8115048

Prostaglandins modulate alterations of microvascular permeability, blood flow, edema and serotonin levels following spinal cord injury: an experimental study in the rat.

H S Sharma1, Y Olsson, F Nyberg, P K Dey.   

Abstract

The possibility that prostaglandins influence edema formation, microvascular permeability increase and reduction of blood flow following spinal cord trauma was examined in a rat model. In addition, the influence of prostaglandins on serotonin metabolism of the traumatized spinal cord was evaluated. Trauma to spinal cord (2-mm-deep and 5-mm-long incision in the right dorsal horn of T10-11 segments) resulted in a profound increase of the water content 5 h after injury. At this time, the microvascular permeability to Evans Blue and [131I]sodium was increased by 457 and 394%, respectively. The blood flow was reduced by 30%. The serotonin (5-hydroxytryptamine) content of the spinal cord increased by 205%. The plasma serotonin level rose by 152% in the injured group of rats. Pretreatment with indomethacin (10 mg/kg, i.p.) 30 min before trauma significantly reduced the edema and microvascular permeability increase. The local spinal cord blood flow of traumatized animals was partially restored. The increases of serotonin levels of the spinal cord and plasma were significantly attenuated. These beneficial effects of indomethacin were not present in rats given a lower dose (5 mg/kg). Indomethacin in either dose did not influence these parameters of control rats without trauma to the cord. Since indomethacin is a potential inhibitor of prostaglandins synthesis our observations indicate: (i) that prostaglandins participate in many microvascular responses (permeability changes, edema, blood flow) occurring after a trauma to the spinal cord; (ii) that these effects of the drug seem to be dose dependent, and (iii) that the prostaglandins may influence the serotonin metabolism following trauma to the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8115048     DOI: 10.1016/0306-4522(93)90076-r

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay.

Authors:  Supriti Samantaray; Joshua A Smith; Arabinda Das; Denise D Matzelle; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2011-05-25       Impact factor: 3.996

2.  Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease.

Authors:  Asya Ozkizilcik; Aruna Sharma; Dafin F Muresanu; José V Lafuente; Z Ryan Tian; Ranjana Patnaik; Herbert Mössler; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 3.  A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.

Authors:  Brian K Kwon; Elena Okon; Jessica Hillyer; Cody Mann; Darryl Baptiste; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-04-14       Impact factor: 5.269

4.  The expression of nerve growth factor receptor on Schwann cells and the effect of these cells on the regeneration of axons in traumatically injured human spinal cord.

Authors:  Z H Wang; G F Walter; L Gerhard
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 5.  Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection.

Authors:  Hari Shanker Sharma
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

Review 6.  Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury.

Authors:  M A Kopp; T Liebscher; A Niedeggen; S Laufer; B Brommer; G J Jungehulsing; S M Strittmatter; U Dirnagl; J M Schwab
Journal:  Cell Tissue Res       Date:  2012-02-21       Impact factor: 5.249

7.  Effect of short-term creatine supplementation on markers of skeletal muscle damage after strenuous contractile activity.

Authors:  Reinaldo Abunasser Bassit; Carlos Hermano da Justa Pinheiro; Kaio Fernando Vitzel; Antônio José Sproesser; Leonardo R Silveira; Rui Curi
Journal:  Eur J Appl Physiol       Date:  2009-12-03       Impact factor: 3.078

8.  Spatial and temporal morphological changes in the subarachnoid space after graded spinal cord contusion in the rat.

Authors:  Horacio J Reyes-Alva; Rebecca E Franco-Bourland; Angelina Martinez-Cruz; Israel Grijalva; Ignacio Madrazo; Gabriel Guizar-Sahagun
Journal:  J Neurotrauma       Date:  2013-06-15       Impact factor: 5.269

9.  Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors.

Authors:  H S Sharma; A Skottner; T Lundstedt; M Flärdh; L Wiklund
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

10.  Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury.

Authors:  Jennifer N Dulin; Edward D Karoly; Ying Wang; Henry W Strobel; Raymond J Grill
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.